Industries > Pharma > Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029

Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings

PUBLISHED: 29 May 2019
PAGES: 155
PRODUCT CODE: PHA0371
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0371 Categories: , Tags: , , , , ,

The global pulmonary/respiratory drug delivery market reached $40.67 bn in 2018 and is expected to grow at a CAGR of 7.60% in 2019-2024. The MDIs segment is estimated to hold a share of 62.4% in 2018. Increasing prevalence and incidence of chronic respiratory diseases is a major factor that is expected to drive the growth of this market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 155-page report you will receive 70 tables and 84 figures– all unavailable elsewhere.

The 155-page report provides clear detailed insight into the global pulmonary/respiratory drug delivery market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Product:
– Formulation: Suspension Aerosol. Solution Aerosol, Dry Powder Formulation
– Devices: Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Canister Type:
– Plain Canisters
– Coated Canister

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by Application:
– Asthma
– COPD
– Cystic Fibrosis
– Other Applications

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2019-2029 by End-User:
– Hospitals & Clinics
– Homecare Settings

• Global Pulmonary/Respiratory Drug Delivery Market forecasts from 2018-2029 by regional and national market:
– North America (US, Canada)
– Europe (Germany, UK, France, Italy, Spain)
– Asia-Pacific (Japan, China, India, Australia, Malaysia)
– RoW (Brazil, Mexico, Turkey, South Africa, Argentina)

• Profiles of the selected leading companies:
– 3M Health Care
– AstraZeneca
– Boehringer Ingelheim GmbH
– GlaxoSmithKline PLC
– Merck & Co., Inc.
– Novartis AG
– OMRON Corporation
– Philips Respironics
– Sunovion Pharmaceuticals Inc.
– Teva Pharmaceutical

• Qualitative analysis of the global pulmonary/respiratory drug delivery market. Discussion on trends, factors that drive and restrain the market as well as Porter’s Five Forces Analysis.

• Key Questions Answered by this Report:
– What are the global revenue prospects for the period 2018 to 2029?
– What are the leading national market potentials from 2018 to 2029?
– How is the respiratory drug delivery market evolving?
– What is driving and restraining the respiratory drug delivery market?
– What are the market shares of each segment of the overall respiratory drug delivery market?
– How will main respiratory drug delivery submarket segments develop over the forecast period and how much revenue will these submarkets account for in 2029?
– How will the market shares for each respiratory drug delivery submarket develop from 2018 to 2029?
– What will be the main commercial drivers for the market from 2018 to 2029?
– How will political and regulatory factors influence that industry and its submarkets?
– How will market shares of prominent national markets change from 2018, and which countries will lead the market in 2029, achieving highest revenues and fastest growth?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market. You find data, trends and predictions.

Buy our report today Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029: Suspension Aerosol, Solution Aerosol, Dry Powder Formulation, Metered Dose Inhalers (MDIS), Dry Powder Inhalers (DPIS), Nebulizers, Accessories, Plain Canister, Coated Canister, Asthma, COPD, Cystic Fibrosis, Other Applications, Hospitals & Clinics, Homecare Settings.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pulmonary/Respiratory Drug Delivery Market Forecast 2019-2029


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category